Dean O - Search Results

1

Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management.

Berk M, Köhler-Forsberg O, Turner M, Penninx BWJH, Wrobel A, Firth J, Loughman A, Reavley NJ, McGrath JJ, Momen NC, Plana-Ripoll O, O'Neil A, Siskind D, Williams LJ, Carvalho AF, Schmaal L, Walker AJ, Dean O, Walder K, Berk L, Dodd S, Yung AR, Marx W. Berk M, et al. Among authors: o neil a, dean o. World Psychiatry. 2023 Oct;22(3):366-387. doi: 10.1002/wps.21110. World Psychiatry. 2023. PMID: 37713568 Free PMC article.

2

A pilot randomized, double-blind, placebo-controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use.

Jespersen S, Berk M, Van Wyk C, Dean O, Dodd S, Szabo CP, Maud C. Jespersen S, et al. Among authors: dean o. Int Clin Psychopharmacol. 2004 May;19(3):161-4. doi: 10.1097/00004850-200405000-00007. Int Clin Psychopharmacol. 2004. PMID: 15107659 Clinical Trial.

3

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications.

Ng F, Berk M, Dean O, Bush AI. Ng F, et al. Among authors: dean o. Int J Neuropsychopharmacol. 2008 Sep;11(6):851-76. doi: 10.1017/S1461145707008401. Epub 2008 Jan 21. Int J Neuropsychopharmacol. 2008. PMID: 18205981 Free article. Review.

4

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial.

Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Judd F, Katz F, Katz P, Ording-Jespersen S, Little J, Conus P, Cuenod M, Do KQ, Bush AI. Berk M, et al. Among authors: dean o. Biol Psychiatry. 2008 Sep 1;64(5):361-8. doi: 10.1016/j.biopsych.2008.03.004. Epub 2008 Apr 23. Biol Psychiatry. 2008. PMID: 18436195 Clinical Trial.

5

N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial.

Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Bush AI. Berk M, et al. Among authors: dean o. Biol Psychiatry. 2008 Sep 15;64(6):468-75. doi: 10.1016/j.biopsych.2008.04.022. Epub 2008 Jun 5. Biol Psychiatry. 2008. PMID: 18534556 Clinical Trial.

6

Glutathione: a novel treatment target in psychiatry.

Berk M, Ng F, Dean O, Dodd S, Bush AI. Berk M, et al. Among authors: dean o. Trends Pharmacol Sci. 2008 Jul;29(7):346-51. doi: 10.1016/j.tips.2008.05.001. Epub 2008 Jun 4. Trends Pharmacol Sci. 2008. PMID: 18538422 Review.

7

N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility.

Dodd S, Dean O, Copolov DL, Malhi GS, Berk M. Dodd S, et al. Among authors: dean o. Expert Opin Biol Ther. 2008 Dec;8(12):1955-62. doi: 10.1517/14728220802517901. Expert Opin Biol Ther. 2008. PMID: 18990082 Review.

8

A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice.

Dean OM, van den Buuse M, Bush AI, Copolov DL, Ng F, Dodd S, Berk M. Dean OM, et al. Curr Med Chem. 2009;16(23):2965-76. doi: 10.2174/092986709788803060. Curr Med Chem. 2009. PMID: 19689277 Review.

9

Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting.

Berk M, Jeavons S, Dean OM, Dodd S, Moss K, Gama CS, Malhi GS. Berk M, et al. CNS Spectr. 2009 Jul;14(7):357-60. doi: 10.1017/s1092852900023002. CNS Spectr. 2009. PMID: 19773711 Free article.

10

Interaction of glutathione depletion and psychotropic drug treatment in prepulse inhibition in rats and mice.

Dean O, Bush AI, Berk M, Copolov DL, van den Buuse M. Dean O, et al. Pharmacol Biochem Behav. 2010 Dec;97(2):293-300. doi: 10.1016/j.pbb.2010.08.013. Epub 2010 Sep 9. Pharmacol Biochem Behav. 2010. PMID: 20816888

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

220 results

Search Page